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Cancer Surveys-Inheritance of susceptibility to
cancer in man. Vol. 1, No. 1. W.F. BODMER, (Guest
editor). Series editor, L.M. FRANKS, Oxford. Oxford
University Press. 188 pp, 1982, £12.00.
"Cancer Surveys" is the first issue of a quarterly
review journal on topics relating to malignancy.
Each issue will explore in depth and review present
knowledge and prospects in specific fields of cancer
research and application. The first number
considers some aspects of inherited cancer
proneness in Man, and, appropriately, W.F.
Bodmer is the Guest Editor. In the opening review,
he looks at the principles that underlie genetic
susceptibility to malignant disease. From this, a
general and crisp summary statement arises, that
"cancer is a genetic disease at the cellular level, but
not a disease with a major inherited component", if
taken over the whole field of malignancy. Bodmer
expands in some detail on the general features that
validate the first part of the statement, including
the clonal origin of some human cancers (but
interest in non-clonal experimental malignancies is
also topical now). The two-step, germinal-plus-
somatic-mutation origin suggested for some
inheritable cancers, Knudson's model, is given
prominence. The Introduction also explores genetic
"systemic" effects, such as those relying on HLA
polymorphisms or genetic variability in the
handling of chemical carcinogens, either at the
general metabolic level (for example, variation in
inducibility of aryl hydrocarbon hydroxylase), or at
the level of their interaction with the chromosomal
DNA. In looking at the various models of genetic
transmission (monogenic, multifactorial, and their
relationship to family clustering), one standard
approach is that of linkage analysis, which,
however, now receives added impetus as it can be
assisted by the detection of chemical DNA
heteromorphisms. Some of these may be especially
useful in practice, when they reach polymorphic
frequencies in the population. These polymorphic
frequencies, however, are not an essential
requirement for intra-family studies, or for the
study of rare tumours, for example. Ultimately, on
the genetic side, the object of cancer research is to
describe how "cancer-genes" function, and here the
opportunity offered by "small" deletions (e.g. in
retinoblastoma) is worthy of especial research
effort. To find out how they operate (and the
mechanism may be different in different situations)
is an important approach.
Under the general umbrella of genetic
contributions to cancer, the monograph contains
excellent reviews by experts. These include twin
studies, based on the population data provided by
the Danish registers (V-lstrup Holm et al); the
epidemiological study of cancer-breast cancer
families (King); the population approach to
prostate cancer in a genetic isolate-the Utah
Mormons (Cannon et al.); in vitro studies on the
special promoter susceptibility of somatic cells from
colorectal cancer-prone subjects (Kopelovich); the
effects of DNA repair defects and ultra-violet or
gamma radiation damage-Xeroderma
pigmentosum and Ataxia telangiectasia, for
example (Lehmann; at the risk of "hardy
speculation", could the production of an
angioblastic factor relate to the relangiectasia?); the
effect of HLA haplotypes on malignancy-
Hodgkin's Lymphoma, but also other cancers, such
as malignant melanoma or renal cancer (Dausset et
al.); and last but not least, the presence of
constitutional structural chromosomal changes in
neoplasia-retinoblastoma and the
aniridia/nephroblastoma complex in particular
(Harnden and Herbert). The final chapter looks
towards the future, and considers the applications
of DNA sequence heteromorphisms and their uses;
it also examines oncogenes and their transcriptional
promoter activity (White).
Altogether an excellent first number of "Cancer
Survey", for which the editor, L.M. Franks, should
be warmly congratulated.
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Interaction of platelets and tumour cells. G.A.
JAMIESON, New York, Alan R. Liss, Inc., 523 pp,
1982.
Platelet involvement in the dissemination of tumour
cells has long been recognised. Recent experimental
data suggest that localised platelet aggregation and
fibrin deposition could affect the
neovascularisation, growth and metastasis of
malignant tumours.
"Interaction of Platelets and Tumour Cells" is a
compilation of papers presented at the Chesapeake
Conference (1981) on that subject. In common with
most conference proceedings, this volume contains
mainly data which has already been published
elsewhere. It has the merit, however, of bringing
together in a coherent way updated information
from several diverse, yet clearly related, fields.